DISCLOSURE: This site receives compensation from featured companies, which may influence rankings. Read Advertising Disclosure
Hims has expanded into testosterone support with an approach that may appeal to men who want to address low testosterone while potentially preserving fertility. Their current primary offering is enclomiphene, a selective estrogen receptor modulator (SERM) that may stimulate the body's own testosterone production rather than replacing it with exogenous hormones. In 2026, Hims is also launching exclusive branded oral testosterone (KYZATREX) in partnership with Marius Pharmaceuticals, along with injectable testosterone options, making it a rapidly growing player in the TRT space.
What We Like
- ✓Enclomiphene may support natural testosterone production without suppressing fertility
- ✓Competitive pricing starting at $99/mo on longer plans
- ✓Expanding to include KYZATREX oral testosterone and injectables in 2026
- ✓All-inclusive pricing with labs, medication, and provider messaging
- ✓Established, trusted telehealth platform with millions of users
- ✓Simple online onboarding and fast medication delivery
Points to Consider
- ✗Enclomiphene is not FDA-approved and is available only through compounding pharmacies
- ✗Traditional injectable TRT is a newer addition — less established track record in this category
- ✗KYZATREX pricing and availability details still emerging
Key Highlights
- Enclomiphene starting at $99/mo on 10-month plans
- Fertility-friendly approach to low testosterone
- Branded oral testosterone (KYZATREX) launching in 2026
- All-inclusive pricing with no surprise fees
- Established telehealth brand trusted by millions
- Injectable testosterone options being added
Pricing Overview
Enclomiphene (10-Month Plan)
Enclomiphene prescribed to support natural testosterone production, paid upfront for 10 months. Includes labs, medication, and provider messaging.
$99/mo
Enclomiphene (5-Month Plan)
Same enclomiphene program with a 5-month commitment and slightly higher monthly rate.
$139/mo
Enclomiphene (3-Month Plan)
Shortest commitment option for enclomiphene with all-inclusive pricing and provider support.
$199/mo
How It Works
Complete Online Assessment
Answer questions about your symptoms, health history, and testosterone-related concerns through a quick online intake on the Hims platform.
Lab Testing
Get lab work ordered to measure your testosterone levels and other relevant biomarkers. Hims coordinates testing through partner labs.
Provider Consultation
A licensed provider reviews your results and discusses treatment options, which may include enclomiphene or other appropriate therapies.
Medication Delivery & Support
If prescribed, your medication ships to your door. Ongoing provider messaging is included to address questions and track your progress.
The Bottom Line
Hims offers a compelling option for men who want to address low testosterone through a fertility-friendly approach, with enclomiphene as the current flagship treatment. The competitive pricing on longer plans and the backing of a major telehealth brand add confidence. With KYZATREX oral testosterone and injectable options launching in 2026, Hims is positioning itself as a comprehensive TRT destination. Note that enclomiphene is not FDA-approved and is available through compounding pharmacies.